Stock TRML TOURMALINE BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts Tourmaline Bio, Inc.

Equities

TRML

US89157D1054

Real-time Estimate Cboe BZX
Other stock markets
 03:10:54 2024-06-12 pm EDT 		5-day change 1st Jan Change
16.1 USD +3.10% Intraday chart for Tourmaline Bio, Inc. +15.89% -38.43%
May. 16 Tourmaline Bio, Inc Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial CI
May. 13 Tourmaline Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Neutral

Bearish

Neutral

Resistance 15.92 23.09 43.19
Spread/Res.+1.26%-30.19%-62.68%
Spread/Supp.+19.85%+19.85%+19.85%
Support 13.45 13.45 13.45

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. TRML Stock
  4. Charts Tourmaline Bio, Inc.